SCHEMBL9208778

SCHEMBL9208778

COc1cccc(NC(=O)c2ccccc2N)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.71
RAB9A P51151 5/20 0.71
KMT2A Q03164 3/20 0.67
KDM4E B2RXH2 2/20 0.67
GAA P10253 1/20 0.67
TP53 P04637 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
POLB P06746 1/20 0.65
NLRP3 Q96P20 1/20 0.65
HPGD P15428 2/20 0.63
FADS1 O60427 1/20 0.63
RXFP1 Q9HBX9 1/20 0.62
KCNK3 O14649 1/20 0.62
KCNK9 Q9NPC2 1/20 0.62
ALDH1A1 P00352 2/20 0.62
USP2 O75604 1/20 0.62
PKM P14618 1/20 0.61
MEN1 O00255 1/20 0.60
TRPV1 Q8NER1 1/20 0.59
PTGS1 P23219 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30726106 1.00 NPC1 (0.71) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL7667058 0.87 FADS1 (0.69) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL28470212 0.86 FADS1 (0.59) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL17744881 0.85 FADS1 (0.72) NPC1RAB9AKMT2AKDM4ESMN1; SMN2
SCHEMBL4436642 0.84 KCNK3 (0.77) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL3209880 0.84 KDM4E (0.73) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL1964197 0.84 NPC1 (0.70) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL30235899 0.84 NPC1 (0.70) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL30758588 0.83 RAB9A (1.00) NPC1RAB9AKMT2AKDM4EGAA
SCHEMBL1499642 0.83 RAB9A (1.00) NPC1RAB9AKMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117510415-A Synthesis method of quinazolinone compound 中国人民解放军军事科学院防化研究院 2024-02-06 CN disclosed
EP-0475755-B1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof LILLY CO ELI (US) 1995-09-27 EP disclosed
US-5196427-A Gastrointestinal and central nervous system disorders; hormone inhibitors ELI LILLY AND COMPANY (US) 1993-03-23 US disclosed
EP-0475755-A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof ELI LILLY AND COMPANY (US) 1992-03-18 EP disclosed
US-5075313-A For bindign to cholecystokinin receptors ELI LILLY AND COMPANY (US) 1991-12-24 US disclosed